Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics